Apr 15 |
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
|
Mar 7 |
Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil
|
Mar 6 |
Estée Lauder, Reckitt, Taro Pharma fall amid cancer risk in acne treatments
|
Jan 30 |
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
|
Jan 25 |
Taro Pharmaceutical GAAP EPS of $0.54 beats by $0.24, revenue of $157.15M beats by $2.24M
|
Jan 25 |
Taro Provides Results for December 31, 2023
|
Jan 24 |
Taro Pharmaceutical Q3 2024 Earnings Preview
|
Dec 29 |
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
|
Dec 22 |
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
|
Dec 12 |
Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity
|